Mosby's 2023 nursing drug reference /
by Skidmore-Roth, Linda,
Series: Thirty-sixth edition Edition statement:Thirty-sixth edition Physical details: x, 1490 pages (5 unnumbered pages) ; 19 cm ISBN:0323930727; 9780323930727.| Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
Books
|
Lending Section (PUMHS Central Library) Pharm-D Library | 610.73 (Browse shelf) | Available | 57803 | |
|
Books
|
Lending Section (PUMHS Central Library) Nursing Library | 610.73 (Browse shelf) | Available | 57804 | |
|
Books
|
Lending Section (PUMHS Central Library) Nursing Library | 610.73 (Browse shelf) | Available | 57805 | |
|
Books
|
Lending Section (PUMHS Central Library) Nursing Library | 610.73 (Browse shelf) | Available | 57806 | |
|
Books
|
Lending Section (PUMHS Central Library) Nursing Library | 610.73 (Browse shelf) | Available | 57807 | |
|
Books
|
Lending Section (PUMHS Central Library) Nursing Library | 610.73 (Browse shelf) | Available | 57808 | |
|
Books
|
Lending Section (PUMHS Central Library) Nursing Library | 610.73 (Browse shelf) | Available | 57809 | |
|
Books
|
Lending Section (PUMHS Central Library) Nursing Library | 610.73 (Browse shelf) | Available | 57810 | |
|
Books
|
Lending Section (PUMHS Central Library) Nursing Library | 610.73 (Browse shelf) | Available | 57811 | |
|
Books
|
Lending Section (PUMHS Central Library) Nursing Library | 610.73 (Browse shelf) | Available | 57812 |
Includes index
Individual drug monographs -- Appendixes: A. Selected new drugs:abametapir ; aducanumab-avwa ; afamelanotide ; anifrolumab-fnia ; asciminib ; atogepant ; avacopan ; avapritinib ; belumosudil ; belzutifan ; bempedoic acid ; brolucizumab-dbll ; difelikefalin ; dostarlimab-gxly - eculizumab ; efavirenz/emtricitabine/tenofovir ; elapegademase-ivir ; elbasvir/grazoprevir ; elexacaftor/tezacaftor/ivacaftor and ivacaftor ; emtricitabine/rilpivirine/tenofovir alafenamide ; enalapril/hydrochlorothiazide ; ephedrine ; factor IX, complex ; factor IX, human ; factor IX, recombinant ; finerenone ; fluocinolone ; fluocinonide ; lonapegsomatropin-tcgd ; loncastuximab tesirine-lpyl ; maribavir ; mobocertinib ; odevixibat ; ropeginterferon alfa-2b ; tisotumab vedotin-tfv ; vosoritide -- B. Ophthalmic, nasal, topical, and otic products -- C. Vaccines and toxoids -- D. Recent FDA drug approvals
Choose the drug handbook trusted by nurses for more than 35 years! Mosby's 2023 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled -- including 35 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides.--From publisher description
There are no comments for this item.